Back
Ocugen Vs. SpringWorks Therapeutics Industry Stock Comparison
Sell
47
OCGN
Ocugen
Last Price:
1.01
Seasonality Move:
168.9%
Buy
64
SWTX
SpringWorks Therapeutics
Last Price:
36.52
Seasonality Move:
54.9%
Sell
47
Ocugen (OCGN)
is a Sell
Is Ocugen a Buy, Sell or Hold?
- The current Ocugen [OCGN] share price is $1.00. The Score for OCGN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- OCGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
SpringWorks Therapeutics (SWTX)
is a Buy
Is SpringWorks Therapeutics a Buy, Sell or Hold?
- The current SpringWorks Therapeutics [SWTX] share price is $36.55. The Score for SWTX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- SWTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
OCGN Stock Price Chart
SWTX Stock Price Chart
What is SpringWorks Therapeutics's stock price today?
-
The SpringWorks Therapeutics share price today is $36.55
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
OCGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 50.71 | Buy |
| Chaikin Money Flow: | -1110139 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.92 - 1) | Buy |
| Bollinger Bands (100): | (0.96 - 1.52) | Sell |
SWTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.68 | Buy |
| Relative Strength Index (14 RSI): | 72.15 | Buy |
| Chaikin Money Flow: | 1709057 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.39 - 33.17) | Buy |
| Bollinger Bands (100): | (31.79 - 39.13) | Buy |
OCGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1 | Sell |
| 20-day SMA: | 0.97 | Buy |
| 50-day SMA: | 1.02 | Sell |
| 200-day SMA: | 1.28 | Sell |
| 8-day EMA: | 1 | Buy |
| 20-day EMA: | 0.99 | Buy |
| 50-day EMA: | 1.05 | Sell |
| 200-day EMA: | 1.16 | Sell |
SWTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.69 | Buy |
| 20-day SMA: | 31.5 | Buy |
| 50-day SMA: | 32.93 | Buy |
| 200-day SMA: | 40.28 | Sell |
| 8-day EMA: | 33.82 | Buy |
| 20-day EMA: | 32.54 | Buy |
| 50-day EMA: | 33.19 | Buy |
| 200-day EMA: | 36.27 | Buy |
Ocugen Earnings Growth & OCGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.07 per share.
SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and an increase next year of $1.42 per share.
Ocugen Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
SpringWorks Therapeutics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||